4-Bromo-2-(prop-1-yn-1-yl)pyridine, 98%, 250mg

5-Chloro-1,3-thiazol-2-amine hydrochloride, 97.0%, 25g

tert-Butyl 3-formylazepane-1-carboxylate, 95%, 5g

6-Bromo-7-fluoroisoquinolin-1(2H)-one, 97%, 250mg

1,3,5-Tris(bromomethyl)-2,4,6-trimethylbenzene, 95.0%, 25g

N-ethyl-2-(4-methylpiperidin-1-yl)ethanamine, 95.0%, 5g

2,5-Bis(trifluoromethyl)phenol, 95.0%, 5g

3-amino-6-(difluoromethyl)-4-methylthieno[2,3-b]pyridine-2-carbonitrile, 95%, 500mg

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 2.00 µm, 1 Piece(s)

3-morpholinomethyl-4'-thiomethylbenzophenone, 97.0%, 1g

3-Hydroxy-2-(trifluoromethyl)benzonitrile, 98%, 1g

(2-Methyl-2H-indazol-6-yl)boronic acid, 97%, 1g

[S(R)]-N-[(R)-[2-(Dicyclohexylphosphino)phenyl]-2-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 100mg